ASX:ALAPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals

AROVELLA THERAPEUTICS ORD

$0.080

Day Range

$0.080 - $0.080

52 Week Range

$0.065 - $0.125

Volume

101.95K

Avg Volume (10D)

637.45K

Market Cap

$96.70M

Price Chart

Market Statistics

Open$0.080

Previous Close$0.080

Day High$0.080

Day Low$0.080

52 Week High$0.125

52 Week Low$0.065

Valuation

Market Cap96.70M

Shares Outstanding1.21B

Price to Book5.40

Trading Activity

Volume101.95K

Value Traded8.16K

Bid$0.078 × 171,617

Ask$0.081 × 30,000

Performance

1 Day11.11%

5 Day6.25%

13 Week0.00%

52 Week-5.56%

YTD-8.60%

Technical Indicators

RSI (14)52.26

50-Day SMA$0.077

200-Day SMA$0.087

Arovella Therapeutics confirms anti-tumour effect of lead drug ALA-101 in treating certain cancers

Arovella Therapeutics (ASX: ALA) has presented new data at the American Association for Cancer Research annual meeting relating to lead drug ALA-101 as a novel ‘off-the-shelf’ therapy to treat CD19-expressing leukemias and lymphomas. The data presented used iNKT (invariant natural killer) cells expressing a chimeric antigen receptor (CAR) which targets the CD19 biomarker. The cells […]

1 min read

Imelda Cotton